P04.1ICD-10-CM 2027
Newborn affected by other maternal medication
Untergeordnete Codes
P04.11– Newborn affected by maternal antineoplastic chemotherapyP04.12– Newborn affected by maternal cytotoxic drugsP04.13– Newborn affected by maternal use of anticonvulsantsP04.14– Newborn affected by maternal use of opiatesP04.15– Newborn affected by maternal use of antidepressantsP04.16– Newborn affected by maternal use of amphetaminesP04.17– Newborn affected by maternal use of sedative-hypnoticsP04.1A– Newborn affected by maternal use of anxiolyticsP04.18– Newborn affected by other maternal medicationP04.19– Newborn affected by maternal use of unspecified medication
Geschwistercodes
P04.0– Newborn affected by maternal anesthesia and analgesia in pregnancy, labor and deliveryP04.2– Newborn affected by maternal use of tobaccoP04.3– Newborn affected by maternal use of alcoholP04.4– Newborn affected by maternal use of drugs of addictionP04.5– Newborn affected by maternal use of nutritional chemical substancesP04.6– Newborn affected by maternal exposure to environmental chemical substancesP04.8– Newborn affected by other maternal noxious substancesP04.9– Newborn affected by maternal noxious substance, unspecified
Code first
Excludes1
Excludes2
Vererbt von P04: Newborn affected by noxious substances transmitted via placenta or breast milk
Code first
- any current condition in newborn, if applicable
Excludes2
- congenital malformations (
Q00-Q99) - encounter for observation of newborn for suspected diseases and conditions ruled out (
Z05.-) - neonatal jaundice from excessive hemolysis due to drugs or toxins transmitted from mother (
P58.4) - newborn in contact with and (suspected) exposures hazardous to health not transmitted via placenta or breast milk (
Z77.-)
Includes
- nonteratogenic effects of substances transmitted via placenta
Teil von: P04: Newborn affected by noxious substances transmitted via placenta or breast milk